• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
In the last 10 minutes
In the last 15 minutes
In the last half-hour
In the last hour
In the last 4 hours
FDA authorises Evusheld for COVID-19 prevention European Pharmaceutical Review05:34
In the last 6 hours
In the last 8 hours
Vaccine Swap Jamaica Gleaner01:05
US authorizes AstraZeneca Covid treatment in some cases Bangladesh Sangbad Sangstha21:58 8-Dec-21
AstraZeneca and Ionis to develop and commercialise eplontersen European Pharmaceutical Review11:07 8-Dec-21
COVAX supplies 600,000 doses of Covishield The Kathmandu Post10:03 8-Dec-21
Luxembourg wasted thousands of unused vaccines Luxembourg Times01:10 8-Dec-21
The history of Covid vaccine development The Guardian01:00 8-Dec-21
In the last 7 days
EU now also backs mix-and-match vaccines Deutsche Welle11:21 7-Dec-21
Diversity is at the heart of innovation Chemistry World Magazine05:18 7-Dec-21
Study at UCLH publishes COVID-19 booster data UCLH NHS Foundation Trust (Press Release)05:17 7-Dec-21
Ionis and AstraZeneca to develop and commercialize eplontersen PR Newswire (Press Release)02:04 7-Dec-21
view more headlines
9 Dec 08:51

AstraZeneca News

NewsNow aims to be the world's most accurate and comprehensive aggregator of AstraZeneca news, covering the latest share price, vaccine news and more from the best online news publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as AstraZeneca news might appear - please feel free to contact us regarding any persistent issues.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.